Beaird Harris Wealth Management’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-74
Closed -$62 612
2023
Q3
$62 Hold
74
﹤0.01% 444
2023
Q2
$89 Hold
74
﹤0.01% 445
2023
Q1
$94 Hold
74
﹤0.01% 466
2022
Q4
$161 Sell
74
-643
-90% -$5.29K ﹤0.01% 720
2022
Q3
$9K Hold
717
﹤0.01% 286
2022
Q2
$6K Hold
717
﹤0.01% 289
2022
Q1
$6K Hold
717
﹤0.01% 404
2021
Q4
$8K Buy
+717
New +$8.52K ﹤0.01% 430

Other funds holding GOSS

Beaird Harris Wealth Management's GOSS Position: Q4 2023 in Review

Beaird Harris Wealth Management sold out of Gossamer Bio (GOSS) in Q4 2023, closing a stake of 74 shares — an estimated $62 sold.

Beaird Harris Wealth Management first reported a position in GOSS in Q4 2021 and held it in 8 quarters. The position peaked at $9K in Q3 2022. 98 funds tracked by Wall St. Rank hold GOSS as of Q4 2023.

  • Beaird Harris Wealth Management reported no remaining Gossamer Bio position as of Q4 2023 after selling out during the quarter.
  • Beaird Harris Wealth Management sold 74 Gossamer Bio shares in Q4 2023, an estimated $62.
  • Beaird Harris Wealth Management first reported a position in Gossamer Bio in Q4 2021 and held it in 8 quarters.
  • Beaird Harris Wealth Management's Gossamer Bio position peaked at $9K in Q3 2022.
  • 98 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2023.

Based on Beaird Harris Wealth Management's 13F filing for Q4 2023, filed 27 Feb 2024.